Published in J Antimicrob Chemother on October 01, 1981
Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.47
Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob Agents Chemother (1990) 1.37
Comparative pharmacokinetics of ceftazidime and moxalactam. Antimicrob Agents Chemother (1982) 1.33
Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrob Agents Chemother (1982) 1.28
Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers. Antimicrob Agents Chemother (1990) 1.14
Pharmacokinetics of ceftazidime in normal and uremic subjects. Antimicrob Agents Chemother (1984) 1.13
Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics. Antimicrob Agents Chemother (1985) 0.93
Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med (1986) 3.34
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25
Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother (1991) 2.81
Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 2.58
Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol (1980) 2.43
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase. J Antimicrob Chemother (1991) 1.91
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.74
Pseudomonas mesophilica infections in humans. J Clin Microbiol (1985) 1.71
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68
Serum cryptococcal antigen determination in the presence of rheumatoid factor. J Clin Microbiol (1981) 1.66
Serum levels of arabinitol in the detection of invasive candidiasis in animals and humans. J Infect Dis (1981) 1.65
Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol (1977) 1.56
Seizure propensity with imipenem. Arch Intern Med (1989) 1.54
Rhino-orbital cerebral mucormycosis. Ear Nose Throat J (1990) 1.53
Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med (1985) 1.52
The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med (1980) 1.50
Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis (1989) 1.49
Vibrio alginolyticus infections in humans. J Clin Microbiol (1979) 1.47
The phylogeny of echinoderm classes based on mitochondrial gene arrangements. J Mol Evol (1993) 1.45
Corynebacterium equi infection complicating neoplastic disease. Am J Clin Pathol (1977) 1.43
Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae. Antimicrob Agents Chemother (1985) 1.40
Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother (1989) 1.34
The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1986) 1.33
Salmonella oslo. A focal outbreak in a hospital. Am J Med (1976) 1.32
Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest (1984) 1.27
Bordetella bronchiseptica peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol (1981) 1.26
Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. J Antimicrob Chemother (1985) 1.20
Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population. Ann Pharmacother (2000) 1.18
Quinolones for the treatment of infections due to Salmonella. Rev Infect Dis (1991) 1.17
Conditions affecting the results of susceptibility testing for the quinolone compounds. Chemotherapy (1988) 1.16
Survival of nosocomial pathogenic bacteria at ambient temperature. J Med (1996) 1.14
Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1990) 1.14
Use of D-lactic acid measurements in the diagnosis of bacterial infections. J Infect Dis (1986) 1.13
Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy. Antimicrob Agents Chemother (1984) 1.12
Evidence for destruction of lung tissues during Pneumocystis carinii infection. Arch Intern Med (1987) 1.10
Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09
Reasons for nonimmunization against influenza in the aged. J Am Geriatr Soc (1989) 1.09
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination. Sabouraudia (1982) 1.08
Non-type b Haemophilus influenzae infections in adults with reference to biotype. J Clin Microbiol (1980) 1.07
Imipenem resistance in Enterobacter. Eur J Clin Microbiol Infect Dis (1993) 1.06
Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J Biol Chem (1990) 1.05
Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis (1994) 1.04
Lumbar puncture-induced meningitis. JAMA (1981) 1.04
Staphylococcus aureus bacteremia during therapy. J Infect Dis (1987) 1.04
Fungal and yeast infections of the central nervous system. A clinical review. Medicine (Baltimore) (1984) 1.04
Penetration of antibiotics into vegetation of heart valves: a mathematical model. Chemotherapy (1982) 1.01
Humoral reactions in human endocarditis due to Streptococcus bovis: evidence for a common S bovis antigen. J Infect Dis (1983) 1.01
In vitro evaluation of the BACTEC resin-containing blood culture bottle. J Clin Microbiol (1983) 1.00
Importance of exfoliatin toxin A production by Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis. J Clin Microbiol (1986) 0.98
The course of cryptococcal capsular polysaccharide antigenemia/human cryptococcal polysaccharide elimination kinetics. Infection (1983) 0.98
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol (1995) 0.97
Experience with the use of cefotaxime in the treatment of bacterial meningitis. Am J Med (1986) 0.97
Non-bacterial infections associated with neoplastic disease. Eur J Cancer (1975) 0.95
Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis. Diagn Microbiol Infect Dis (1988) 0.94
Inhibition of 40S--Met--tRNAfMet ribosomal initiation complex formation by vaccinia virus. Nature (1980) 0.94
Cefmenoxime therapy of serious bacterial infections. Antimicrob Agents Chemother (1984) 0.94
Recovery of blood-borne bacteria from human urine. J Infect (1985) 0.93
Antifungal activity in human urine and serum after ingestion of garlic (Allium sativum). Antimicrob Agents Chemother (1983) 0.93
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens. Diagn Microbiol Infect Dis (1992) 0.93
Aberrant form of Pseudomonas aeruginosa in sputum and cerebrospinal fluid causing infection in a compromised patient. J Clin Pathol (1978) 0.92
Epidemiology of Klebsiella antibiotic resistance and serotypes. J Clin Microbiol (1982) 0.92
Precipitating antibodies in mycoplasma infection. J Clin Microbiol (1977) 0.92
Legionnaires' disease in a gravedigger. An epidemiologic study. N Y State J Med (1984) 0.92
Acute disseminated tuberculosis as a diagnostic problem. A clinical study based on twenty-eight cases. Am Rev Respir Dis (1974) 0.92
Gene arrangement in sea star mitochondrial DNA demonstrates a major inversion event during echinoderm evolution. Gene (1989) 0.92
Susceptibility of Zygomycetes to human serum. Sabouraudia (1981) 0.91
The translation of the messenger for the poly(A)-binding protein-associated with translated mRNA is suppressed. A case of cytoplasmic repression in duck erythroblasts. FEBS Lett (1983) 0.91
Bacteremia and fungemia in patients with acquired immune deficiency syndrome. Am J Clin Pathol (1986) 0.91
Nucleotide sequence of nine protein-coding genes and 22 tRNAs in the mitochondrial DNA of the sea star Pisaster ochraceus. J Mol Evol (1990) 0.91
Involvement of Gardnerella vaginalis in urinary tract infections in men. J Clin Microbiol (1992) 0.90
Yield of bone marrow culture in the diagnosis of infectious diseases in patients with acquired immunodeficiency syndrome. J Clin Microbiol (1986) 0.90
Colonization pattern of vancomycin-resistant Enterococcus faecium. Am J Infect Control (1994) 0.89
Thymidine-dependent strain of Salmonella oslo selected by trimethoprim-sulfamethoxazole therapy. Am J Clin Pathol (1977) 0.89
Change in serum pH in the bioassay of aminoglycoside antibiotics. J Infect Dis (1982) 0.89
Nontyphoid salmonella urinary tract infections. Diagn Microbiol Infect Dis (1987) 0.88
Cefamandole for the therapy of serious Staphylococcus aureus infections. J Antimicrob Chemother (1985) 0.87
Infections caused by Actinomyces viscosus. Am J Clin Pathol (1981) 0.87
Salmonella infections in patients with acquired immunodeficiency syndrome. Arch Intern Med (1985) 0.87
Cerebral mucormycosis and renal aspergillosis in heroin addicts without endocarditis. Am J Med Sci (1973) 0.87
Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens. Transplant Proc (1978) 0.87
D-lactic acid measurements in the diagnosis of bacterial infections. J Clin Microbiol (1989) 0.86
Inhibition of host protein synthesis in vaccinia virus-infected cells in the presence of cordycepin (3'-deoxyadenosine). J Virol (1978) 0.85
Vitamin K supplementation during prophylactic use of cefoperazone in urologic surgery. Infection (1992) 0.82
Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. Am J Crit Care (1993) 0.82
Blunt trauma and liver abscess. Am J Gastroenterol (1981) 0.82
Brain lesions in patients with acquired immunodeficiency syndrome. Arch Intern Med (1989) 0.82
Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis. Antimicrob Agents Chemother (1986) 0.81
Translation in micrococcal nuclease-treated cell-free extracts from Ehrlich ascites tumor cells. Stimulation by initiation factor eIF-2B. Biochim Biophys Acta (1984) 0.81
Detection of bacterial antigens in body fluids by the Phadebact system. Scand J Infect Dis (1986) 0.81
Studies on multi-antibiotic resistant strains of Staphylococcus aureus. Infection (1982) 0.81
Hemoglobin S/C disease in a pregnant woman with crisis and fat embolization syndrome. Am J Med (1975) 0.81